Loading organizations...
§ Private Profile · USA
Biopharmaceutical company developing drugs for CNS disorders.
Myosin Therapeutics has raised $5.0M across 2 funding rounds.
Myosin Therapeutics has raised $5.0M in total across 2 funding rounds.
Myosin Therapeutics has raised $5.0M in total across 2 funding rounds.
Myosin Therapeutics's investors include Florida Department of Health, Dave Adams, DeepWork Capital, Florida Opportunity Fund, Dynagrow Capital, Mayo Clinic, Sontag Foundation.
Myosin Therapeutics has raised $5.0M across 2 funding rounds. Most recently, it raised $2.0M Grant in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2026 | $2M Undisclosed | Florida Department OF Health | — | Announced |
| Mar 3, 2025 | $3M Seed | Dave Adams, DeepWork Capital, Florida Opportunity Fund, Mint12 Pharma | Dynagrow Capital, Mayo Clinic, Sontag Foundation | Announced |